Strong volume growth masks margin compression; commodity inflation unresolved
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Gross margin aspiration 32% not achieved (delivered 29%); EBITDA 6.5% vs 7% prior; path to double-digit reaffirmed but hedged.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong 25% revenue growth and 124% PAT surge are driven by volume momentum and cost discipline, but delivered gross margin (29%) falls short of prior 32-34% aspiration; management hedges near-term recovery to 30-31% conditional on commodity price stabilization, which remains unpredictable. Path to double-digit EBITDA is credible (new products, distribution, premiumization) but timeline unspecified; near-term margin headwind and elevated working capital (34 days) cap upside.
₹879.3 Cr
Revenue · +25.2% YoY₹27.1 Cr
Reported PAT · +124.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 25.2% YoY to ₹879 Cr
METDelivered ₹879.3 Cr, segment breakdown: lighting 25.7%, ECD 24.9%, appliances double-digit
PAT more than doubled
METDelivered ₹27.1 Cr, +124.4% YoY; EBITDA grew 49.7% to ₹57 Cr
Gross margins 29%
METDelivered 29%, vs prior aspiration of 32-34%; commodity inflation cited
EBITDA margin expanded 106 bps to 6.5%
METDelivered 6.5% vs prior ~5.5%; but below prior 7% guidance target
Project Sanchay generated ₹13 Cr Q2 savings, ₹23 Cr H1
METManagement cited ₹13 Cr Q2, ₹23 Cr H1 cost optimization; ₹70 Cr full-year H1 basis
New products at 90%+ success rate, 30% of fan revenue
METManagement stated 90%+ success rate, 30%+ of fans from NPD, commercialization robust
Price hikes 3-6% Q2, 3% October to offset inflation
METManagement detailed category-wise hikes; fans 6-7% Q1, 6% Q2; appliances 3% Q2; wires latest entrant pace-following
Gross margin recovery to 30-31% next quarter expected
OVERSTATEDManagement hedged: 'assuming last quarter would be half absorption, so next qtr onward should we expect that range?' — unconfirmed
Earnings quality
What changed since the last call
Gross margin recovery hedged
DowngradePrior call guided 32-34% aspiration; Q2 delivered 29%; Q3 expectation softened to 30-31% with caveats; long-term 32% reaffirmed but interim pressure acknowledged.
EBITDA margin timing pushed out
NeutralPrior 7% target delivered at 6.5%; double-digit path reaffirmed but no specific fiscal year given; management says H2 better, Q3-Q4 much better, but unquantified.
Revenue growth momentum reconfirmed
UpgradeRunning 24.3% H1 growth; management now guides >15% CAGR FY27 (vs prior 14-15% multi-year target); implies upside to ₹5,000 Cr milestone trajectory.
Distribution expansion acceleration
NewDTM (direct-to-market) rollout in 15 states; fresh launches in Punjab, Nagpur; management expects margin-accretive mix and market share gains; concrete execution vs prior aspirational language.
The Q&A
Analysts pressed hard on margin recovery timeline, competitive intensity, working capital deterioration, and commodity outlook. Management held firm on strategy (premiumization, new products) but hedged on commodity predictability and exact margin recovery timing. No evasion; realistic tone on headwinds.
Price hikes & inventory — Aniruddha Joshi, ICICI Securities
AnsweredNo abnormal primary stocking; pricing consistent with demand pull. Base strong vs industry. BLDC growth will be 17-18% of ceiling fans in next quarters.
R&D and NPD success — Balasubramanian, Arihant Capital
AnsweredR&D ~0.8-0.9% of turnover. Success measured by market share gains, product reach uptake, third-party validation. New products 30%+ of fan revenue; 90%+ success rate.
Operating margin path — Madhur Rathi, Counter Cyclical
Partial104 bps improvement YoY achieved; Q3-Q4 much better seasonally. H2 onwards better EBITDA %; Project Sanchay ₹23 Cr H1 savings; H2 cost programs ongoing.
FY27 growth sustainability — Naushad Chaudhary, Aditya Birla Sun Life
Partial>15% CAGR guided for FY27. Gross margin recovery 30-31% expected next qtr 'assuming' inflation abates; long-run 32% target maintained.
Distribution & segmental mix — Lakshminarayanan, Tunga
AnsweredB2B ~25% of lighting. DTM expansion in MP, CG, JK; value ~1 lakh outlets planned. Steel +65-80%, plastics up, copper very volatile.
Facility utilization & capacity — Nikhat Koor, Dolat Capital
AnsweredHyderabad ~40% util, scaling Q3-Q4; 75% PPW, 20-25% ceiling fans. Wires North/East launched; not pan-India yet; selective high-preference markets.
New facility impact & BLDC — Yash Jain, Ambit Capital
AnsweredHyderabad 20-30 bps margin improvement. BLDC industry growing, OEL outpacing via superior quality, PCB design, tech tie-ups (Slovenia, Eurotech range).
A&P spend & gross margin deflators — Nirranh Jain, BNP Paribas
AnsweredQ1 higher due to fan season. 15-18% price hike 9-month cumulative; ~80% inflation covered; 20% gap remains. BLDC ASP improving; competitive intensity ongoing.
Guidance
FY27 revenue growth >15% CAGR
HighCurrently running 24.3% H1; trajectory above prior 14-15% multi-year guidance; ₹5,000 Cr milestone tracking ahead of schedule.
Gross margin 32% long-term aspiration
MediumDelivered 29% Q2; Q3 expectation 30-31% contingent on commodity abatement; management committed but inflation timeline unpredicatable.
EBITDA margin path to double-digit
MediumQ2 delivered 6.5% vs prior 7%; H2 expected better; Q3-Q4 seasonally stronger; timeline unspecified; supported by mix, cost programs, productivity.
Risks the call surfaced
Commodity inflation
HighCopper, steel, aluminum, plastics all elevated; Q2 price hikes (3-6%) covered ~80% of inflation; 20% unabsorbed gap remains. Timing of reversal unpredictable.
Working capital
MediumWorking capital days jumped to 34 from 16-17 due to DTM channel financing and newer segment entry. Path to ~20 days outlined but execution-dependent over 4-6 qtr.
Competitive intensity
MediumUnorganized players gaining share in lower-end segments as inflation forces organized brands to raise prices. Orient's premiumization mitigates but lower-tier portfolio at risk.
New product execution
Low30%+ of fan revenue from new products at 90%+ success rate; if innovation cycle slows or consumer adoption stalls, growth driver compromised.
Distribution expansion
MediumDTM rollout in 15 states (MP, CG, JK, Punjab, Nagpur) aims for ~1 lakh outlets; margin-accretive mix (premiumization, BLDC) assumes successful channel absorption and sell-through.
Management
Score 7/10. Clear on segment performance and new products; specific on cost savings (Project Sanchay ₹23 Cr H1); realistic on commodity headwinds but hedges on recovery timeline. Revenue growth 25.2% vs guidance; cost programs delivering (₹23 Cr H1); EBITDA margin 6.5% vs 7% prior (slight miss); gross margin 29% vs 32-34% aspiration (material miss).
1 · Q3-Q4 FY27
Gross margin recovery to 30-31% as commodity inflation abates; EBITDA margin trajectory toward double-digit
2 · H2 FY27
Distribution footprint expansion in 15 states (DTM model); Madhya Pradesh, Chhattisgarh, Jharkhand execution
3 · FY28+
₹5,000 Cr revenue milestone at 14-15% CAGR; new product portfolio (BLDC, Nixa Shield, Aero innovations) scale-up and market share gains
Path to double-digit EBITDA is credible (new products, distribution, premiumization) but timeline unspecified; near-term margin headwind and elevated working capital (34 days) cap upside.
Informational and educational content only. Not investment advice.